Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimazolam vs propofol for postoperative recovery after renal transplantation
ChiCTR2500112542Phase 4Not yet recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in chronic kidney disease (CKD) and end-stage kidney disease (ESKD) comparing Propofol maintenance anesthesia with Remimazolam maintenance anesthesia (2 arms). Primary endpoint: QoR-15 score 24 hours after operation. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
propofolremimazolam
03
Conditions
chronic kidney disease (CKD)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR2500112542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112542.